Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Past 7 days
    • Any time
    • Past hour
    • Past 24 hours
    • Past 30 days
The Lancet
6d

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

Copyright: © 2016 Elsevier Ltd. All rights reserved.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

Musk loses OpenAI lawsuit
Trump drops $10B IRS suit
Rare tornado threat issued
Acquitted of tax fraud
Cooper signs off '60 Minutes'
Two arrested in zoo stunt
China to boost US agri trade
2 US jets collide mid-air
Austin shootings: Teens held
To arrive in Netherlands
Oil prices rise
Italian divers’ bodies found
Earthquake in China
Thousands attend prayer rally
Attacks on Nigeria schools
Signs 5-year deal with EDF
House explosion in Illinois
HBCU football star dies at 22
Rejects pharma appeals
Gun, notebook allowed in trial
HK court hears final arguments
Sinner wins Italian Open
To unveil AI encyclical
Launches joint drills with RU
Philippines opens VP trial
To buy Dominion Energy
Pelicans hire head coach
To skip Cannes Palme d’Or
Wins 2nd straight NBA MVP
  • Privacy
  • Terms